Nina Wagner-Johnston

Associate Professor

19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

1999

Non-Hodgkin's lymphomas.

Bartlett, N. L. & Wagner, N. D., 1999, In : Cancer chemotherapy and biological response modifiers. 18, p. 293-323 31 p.

Research output: Contribution to journalReview article

2001

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854

Bartlett, N. L., Petroni, G. R., Parker, B. A., Wagner, N. D., Gockerman, J. P., Omura, G. A., Canellos, G. P., Robertcooper, M., Johnson, J. L. & Peterson, B. A., Jul 15 2001, In : Cancer. 92, 2, p. 207-217 11 p.

Research output: Contribution to journalArticle

2007

Epstein-Barr virus-related lymphoproliferative disorders

Wagner-Johnston, N. D. & Ambinder, R. F., Dec 1 2007, In : Current Hematologic Malignancy Reports. 2, 4, p. 249-254 6 p.

Research output: Contribution to journalReview article

2008

Blood and marrow transplant for lymphoma patients with HIV/AIDS

Wagner-Johnston, N. D. & Ambinder, R. F., Mar 1 2008, In : Current opinion in oncology. 20, 2, p. 201-205 5 p.

Research output: Contribution to journalReview article

2009

Phase II study of 9-aminocamptothecin in previously treated lymphomas: Results of Cancer and Leukemia Group B 9551

Bartlett, N. L., Johnson, J. L., Wagner-Johnston, N., Ratain, M. J. & Peterson, B. A., Apr 1 2009, In : Cancer Chemotherapy and Pharmacology. 63, 5, p. 793-798 6 p.

Research output: Contribution to journalArticle

Something old, something new: Options for treating relapsed mantle cell lymphoma

Wagner-Johnston, N. D. & Bartlett, N. L., Jul 14 2009, In : ONCOLOGY. 23, 8

Research output: Contribution to journalComment/debate

2010
2011

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

Fehniger, T. A., Larson, S., Trinkaus, K., Siegel, M. J., Cashen, A. F., Blum, K. A., Fenske, T. S., Hurd, D. D., Goy, A., Schneider, S. E., Keppel, C. R., Wagner-Johnston, N. D., Carson, K. R. & Bartlett, N. L., Nov 10 2011, In : Blood. 118, 19, p. 5119-5125 7 p.

Research output: Contribution to journalArticle

Clonal immunoglobulin DNA in the plasma of patients with AIDS lymphoma

Wagner-Johnston, N. D., Gellert, L., Gocke, C. D., Lemas, V. M., Lee, J., Martínez-Maza, O. & Ambinder, R. F., May 5 2011, In : Blood. 117, 18, p. 4860-4862 3 p.

Research output: Contribution to journalArticle

De novo large B-cell lymphoma in a parenchymal brain lesion: Evidence of clonal evolution from splenic marginal zone lymphoma

Fadugba, O., Nguyen, T. D. T., McGill, J. & Wagner-Johnston, N., Mar 20 2011, In : Journal of Clinical Oncology. 29, 9, p. e234-e236

Research output: Contribution to journalArticle

IgH gene rearrangements as plasma biomarkers in non-Hodgkin's Lymphoma patients

He, J., Wu, J., Jiao, Y., Wagner-Johnston, N., Ambinder, R. F., Diaz, L. A., Kinzler, K. W., Vogelstein, B. & Papadopoulos, N., 2011, In : Oncotarget. 2, 3, p. 178-185 8 p.

Research output: Contribution to journalArticle

Open Access

Role of routine imaging in lymphoma

Wagner-Johnston, N. D. & Bartlett, N. L., May 1 2011, In : JNCCN Journal of the National Comprehensive Cancer Network. 9, 5, p. 575-585 11 p.

Research output: Contribution to journalArticle

2012

Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

Wagner-Johnston, N. D., Bartlett, N. L., Cashen, A. & Berger, J. R., Nov 1 2012, In : Leukemia and Lymphoma. 53, 11, p. 2283-2286 4 p.

Research output: Contribution to journalLetter

2013

Computer/online-mediated social support for cancer-related fatigue

Wagner-Johnston, N., Oct 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 10, p. 1211-1217 7 p.

Research output: Contribution to journalArticle

2014

A 54 Year-old man with progressive vision and hearing loss

Gru, A. A., Kolar, G., Wagner-Johnston, N. D., Schmidt, R. & Yaseen, N. R., Mar 1 2014, In : Brain Pathology. 24, 2, p. 197-200 4 p.

Research output: Contribution to journalComment/debate

A phase 1 study of the PI3Kd inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)

Kahl, B. S., Spurgeon, S. E., Furman, R. R., Flinn, I. W., Coutre, S. E., Brown, J. R., Benson, D. M., Byrd, J. C., Peterman, S., Cho, Y., Yu, A., Godfrey, W. R. & Wagner-Johnston, N. D., May 29 2014, In : Blood. 123, 22, p. 3398-3405 8 p.

Research output: Contribution to journalArticle

Diffusion-weighted MRI for staging and evaluation of response in diffuse large B-cell lymphoma: A pilot study

Siegel, M. J., Jokerst, C. E., Rajderkar, D., Hildebolt, C. F., Goyal, S., Dehdashti, F., Wagner Johnston, N. & Siegel, B. A., Jun 2014, In : NMR in biomedicine. 27, 6, p. 681-691 11 p.

Research output: Contribution to journalArticle

High incidence of methotrexate associated renal toxicity in patients with lymphoma: A retrospective analysis

May, J., Carson, K. R., Butler, S., Liu, W., Bartlett, N. L. & Wagner-Johnston, N. D., Jun 2014, In : Leukemia and Lymphoma. 55, 6, p. 1345-1349 5 p.

Research output: Contribution to journalArticle

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

Brown, J. R., Byrd, J. C., Coutre, S. E., Benson, D. M., Flinn, I. W., Wagner-Johnston, N. D., Spurgeon, S. E., Kahl, B. S., Bello, C., Webb, H. K., Johnson, D. M., Peterman, S., Li, D., Jahn, T. M., Lannutti, B. J., Ulrich, R. G., Yu, A. S., Miller, L. L. & Furman, R. R., May 29 2014, In : Blood. 123, 22, p. 3390-3397 8 p.

Research output: Contribution to journalArticle

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma

Flinn, I. W., Kahl, B. S., Leonard, J. P., Furman, R. R., Brown, J. R., Byrd, J. C., Wagner-Johnston, N. D., Coutre, S. E., Benson, D. M., Peterman, S., Cho, Y., Webb, H. K., Johnson, D. M., Yu, A. S., Ulrich, R. G., Godfrey, W. R., Miller, L. L. & Spurgeon, S. E., May 29 2014, In : Blood. 123, 22, p. 3406-3413 8 p.

Research output: Contribution to journalArticle

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission

Pingali, S. R., Jewell, S. W., Havlat, L., Bast, M. A., Thompson, J. R., Eastwood, D. C., Bartlett, N. L., Armitage, J. O., Wagner-Johnston, N. D., Vose, J. M. & Fenske, T. S., Jan 1 2014, In : Cancer. 120, 14, p. 2122-2129 8 p.

Research output: Contribution to journalArticle

Management options for established chemotherapy-induced peripheral neuropathy

Pachman, D. R., Watson, J. C., Lustberg, M. B., Wagner-Johnston, N. D., Chan, A., Broadfield, L., Cheung, Y. T., Steer, C., Storey, D. J., Chandwani, K. D., Paice, J., Jean-Pierre, P., Oh, J., Kamath, J., Fallon, M., Strik, H., Koeppen, S. & Loprinzi, C. L., Aug 2014, In : Supportive Care in Cancer. 22, 8, p. 2281-2295 15 p.

Research output: Contribution to journalReview article

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

Gopal, A. K., Kahl, B. S., Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., Flinn, I. W., Flowers, C. R., Martin, P., Viardot, A., Blum, K. A., Goy, A. H., Davies, A. J., Zinzani, P. L., Dreyling, M., Johnson, D., Miller, L. L., Holes, L., Li, D., Dansey, R. D. & 2 others, Godfrey, W. R. & Salles, G. A., Jan 1 2014, In : New England Journal of Medicine. 370, 11, p. 1008-1018 11 p.

Research output: Contribution to journalArticle

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline

Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., Paice, J., Schneider, B., Smith, M. L., Smith, T., Terstriep, S., Wagner-Johnston, N., Bak, K. & Loprinzi, C. L., Jun 20 2014, In : Journal of Clinical Oncology. 32, 18, p. 1941-1967 27 p.

Research output: Contribution to journalReview article

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

Carson, K. R., Newsome, S. D., Kim, E. J., Wagner-Johnston, N. D., Von Geldern, G., Moskowitz, C. H., Moskowitz, A. J., Rook, A. H., Jalan, P., Loren, A. W., Landsburg, D., Coyne, T., Tsai, D., Raisch, D. W., Norris, L. B., Bookstaver, P. B., Sartor, O. & Bennett, C. L., Aug 15 2014, In : Cancer. 120, 16, p. 2464-2471 8 p.

Research output: Contribution to journalArticle

2015

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

Wagner-Johnston, N. D., Sloan, J. A., Liu, H., Kearns, A. E., Hines, S. L., Puttabasavaiah, S., Dakhil, S. R., Lafky, J. M., Perez, E. A. & Loprinzi, C. L., Aug 1 2015, In : Cancer. 121, 15, p. 2537-2543 7 p.

Research output: Contribution to journalArticle

AMC 048: Modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma

AIDS Malignancy Consortium, Jul 9 2015, In : Blood. 126, 2, p. 160-166 7 p.

Research output: Contribution to journalArticle

A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma

Wagner-Johnston, N. D., Goy, A., Rodriguez, M. A., Ehmann, W. C., Hamlin, P. A., Radford, J., Thieblemont, C., Suh, C., Sweetenham, J., Huang, Y., Sullivan, S. T., Vandendries, E. R. & Gisselbrecht, C., Oct 3 2015, In : Leukemia and Lymphoma. 56, 10, p. 2863-2869 7 p.

Research output: Contribution to journalArticle

Cancer-related fatigue, version 2.2015

Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., Jacobsen, P. B., Jankowski, C., LeBlanc, T., Ligibel, J. A., Loggers, E. T., Mandrell, B., Murphy, B. A., Palesh, O., Pirl, W. F., Plaxe, S. C. & 8 others, Riba, M. B., Rugo, H. S., Salvador, C., Wagner, L. I., Wagner-Johnston, N. D., Zachariah, F. J., Bergman, M. A. & Smith, C., Aug 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 8, p. 1012-1039 28 p.

Research output: Contribution to journalReview article

Open Access

Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (Alliance)

Pachman, D. R., Qin, R., Seisler, D. K., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J. M., Wagner-Johnston, N. D., Ruddy, K. J., Dakhil, S., Staff, N. P., Grothey, A. & Loprinzi, C. L., Oct 20 2015, In : Journal of Clinical Oncology. 33, 30, p. 3416-3422 7 p.

Research output: Contribution to journalArticle

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma

Carson, K. R., Riedell, P., Lynch, R., Nabhan, C., Wildes, T. M., Liu, W., Ganti, A., Roop, R., Sanfilippo, K. M., O'Brian, K., Liu, J., Bartlett, N. L., Cashen, A., Wagner-Johnston, N., Fehniger, T. A. & Colditz, G. A., May 1 2015, In : Journal of Geriatric Oncology. 6, 3, p. 211-218 8 p.

Research output: Contribution to journalArticle

Outcomes of transformed follicular lymphoma in the modern era: A report from the National LymphoCare Study (NLCS)

Wagner-Johnston, N. D., Link, B. K., Byrtek, M., Dawson, K. L., Hainsworth, J., Flowers, C. R., Friedberg, J. W. & Bartlett, N. L., Aug 13 2015, In : Blood. 126, 7, p. 851-857 7 p.

Research output: Contribution to journalArticle

Phase II intergroup trial of alisertib in relapsed and refractory peripheral T-cell lymphoma and transformed Mycosis fungoides: SWOG 1108

Barr, P. M., Li, H., Spier, C., Mahadevan, D., LeBlanc, M., Ul Haq, M., Huber, B. D., Flowers, C. R., Wagner-Johnston, N. D., Horwitz, S. M., Fisher, R. I., Cheson, B. D., Smith, S. M., Kahl, B. S., Bartlett, N. L. & Friedberg, J. W., Jul 20 2015, In : Journal of Clinical Oncology. 33, 21, p. 2399-2404 6 p.

Research output: Contribution to journalArticle

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness a randomized clinical trial

Kutner, J. S., Blatchford, P. J., Taylor, D. H., Ritchie, C. S., Bull, J. H., Fairclough, D. L., Hanson, L. C., LeBlanc, T. W., Samsa, G. P., Wolf, S., Aziz, N. M., Currow, D. C., Ferrell, B., Wagner-Johnston, N., Zafar, S. Y., Cleary, J. F., Dev, S., Goode, P. S., Kamal, A. H., Kassner, C. & 10 others, Kvale, E. A., McCallum, J. G., Ogunseitan, A. B., Pantilat, S. Z., Portenoy, R. K., Prince-Paul, M., Sloan, J. A., Swetz, K. M., Von Gunten, C. F. & Abernethy, A. P., May 1 2015, In : JAMA internal medicine. 175, 5, p. 691-700 10 p.

Research output: Contribution to journalArticle

2016

A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy

Goy, A., Forero, A., Wagner-Johnston, N., Christopher Ehmann, W., Tsai, M., Hatake, K., Ananthakrishnan, R., Volkert, A., Vandendries, E. & Ogura, M., Aug 1 2016, In : British Journal of Haematology. 174, 4, p. 571-581 11 p.

Research output: Contribution to journalArticle

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Pachman, D. R., Qin, R., Seisler, D., Smith, E. M. L., Kaggal, S., Novotny, P., Ruddy, K. J., Lafky, J. M., Ta, L. E., Beutler, A. S., Wagner-Johnston, N., Staff, N. P., Grothey, A., Dougherty, P. M., Cavaletti, G. & Loprinzi, C. L., Aug 18 2016, (Accepted/In press) In : Supportive Care in Cancer. p. 1-10 10 p.

Research output: Contribution to journalArticle

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Zimmerman, C., Atherton, P. J., Pachman, D., Seisler, D., Wagner-Johnston, N., Dakhil, S., Lafky, J. M., Qin, R., Grothey, A. & Loprinzi, C. L., Mar 1 2016, In : Supportive Care in Cancer. 24, 3, p. 1071-1078 8 p.

Research output: Contribution to journalArticle

Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria

Rashidi, A., Oak, E., Carson, K. R., Wagner-Johnston, N. D., Kreisel, F. & Bartlett, N. L., May 3 2016, In : Leukemia and Lymphoma. 57, 5, p. 1191-1193 3 p.

Research output: Contribution to journalLetter

Postibrutinib outcomes in patients with mantle cell lymphoma

Martin, P., Maddocks, K., Leonard, J. P., Ruan, J., Goy, A., Wagner-Johnston, N., Rule, S., Advani, R., Iberri, D., Phillips, T., Spurgeon, S., Kozin, E., Noto, K., Chen, Z., Jurczak, W., Auer, R., Chmielowska, E., Stilgenbauer, S., Bloehdorn, J., Portell, C. & 7 others, Williams, M. E., Dreyling, M., Barr, P. M., Chen-Kiang, S., DiLiberto, M., Furman, R. R. & Blum, K. A., Mar 24 2016, In : Blood. 127, 12, p. 1559-1563 5 p.

Research output: Contribution to journalArticle

Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: A center for international blood and marrow transplant research analysis

Ghosh, N., Karmali, R., Rocha, V., Ahn, K. W., DiGilio, A., Hari, P. N., Bachanova, V., Bacher, U., Dahi, P., De Lima, M., D'Souza, A., Fenske, T. S., Ganguly, S., Kharfan-Dabaja, M. A., Prestidge, T. D., Savani, B. N., Smith, S. M., Sureda, A. M., Waller, E. K., Jaglowski, S. & 7 others, Herrera, A. F., Armand, P., Salit, R. B., Wagner-Johnston, N. D., Fuchs, E., Bolaños-Meade, J. & Hamadani, M., Sep 10 2016, In : Journal of Clinical Oncology. 34, 26, p. 3141-3149 9 p.

Research output: Contribution to journalArticle

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up

Majithia, N., Atherton, P. J., Lafky, J. M., Wagner-Johnston, N., Olson, J., Dakhil, S. R., Perez, E. A., Loprinzi, C. L. & Hines, S. L., Mar 1 2016, In : Supportive Care in Cancer. 24, 3, p. 1219-1226 8 p.

Research output: Contribution to journalArticle

2017

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

Garzon, R., Savona, M., Baz, R., Andreeff, M., Gabrail, N., Gutierrez, M., Savoie, L., Mau-Sorensen, P. M., Wagner-Johnston, N., Yee, K., Unger, T. J., Saint-Martin, J. R., Carlson, R., Rashal, T., Kashyap, T., Klebanov, B., Shacham, S., Kauffman, M. & Stone, R., Jun 15 2017, In : Blood. 129, 24, p. 3165-3174 10 p.

Research output: Contribution to journalArticle

A phase 2/3 multicenter, randomized, open-label study to compare the efficacy and safety of lenalidomide versus investigator's choice in patients with relapsed or refractory diffuse large B-cell lymphoma

Czuczman, M. S., Trněný, M., Davies, A., Rule, S., Linton, K. M., Wagner-Johnston, N., Gascoyne, R. D., Slack, G. W., Brousset, P., Eberhard, D. A., Hernandez-Ilizaliturri, F. J., Salles, G., Witzig, T. E., Zinzani, P. L., Wright, G. W., Staudt, L. M., Yang, Y., Williams, P. M., Lih, C. J., Russo, J. & 5 others, Thakurta, A., Hagner, P., Fustier, P., Song, D. & Lewis, I. D., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4127-4137 11 p.

Research output: Contribution to journalArticle

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

Maly, J. J., Christian, B. A., Zhu, X., Wei, L., Sexton, J. L., Jaglowski, S. M., Devine, S. M., Fehniger, T. A., Wagner-Johnston, N., Phelps, M. A., Bartlett, N. L. & Blum, K. A., Jun 1 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 6, p. 347-353 7 p.

Research output: Contribution to journalArticle

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial

Jones, J. A., Robak, T., Brown, J. R., Awan, F. T., Badoux, X., Coutre, S., Loscertales, J., Taylor, K., Vandenberghe, E., Wach, M., Wagner-Johnston, N., Ysebaert, L., Dreiling, L., Dubowy, R., Xing, G., Flinn, I. W. & Owen, C., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e114-e126

Research output: Contribution to journalArticle

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: A subgroup analysis of a phase 2 study

Salles, G., Schuster, S. J., De Vos, S., Wagner-Johnston, N. D., Viardot, A., Blum, K. A., Flowers, C. R., Jurczak, W. J., Flinn, I. W., Kahl, B. S., Martin, P., Kim, Y., Shreay, S., Will, M., Sorensen, B., Breuleux, M., Zinzani, P. L. & Gopal, A. K., Mar 31 2017, In : Haematologica. 102, 4, p. e156-e159

Research output: Contribution to journalLetter

Hairy cell Leukemia, Version 2.2018: Clinical practice guidelines in oncology

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bhat, S., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Lancet, J., Ma, S., Malek, S. & 6 others, Mosse, C., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N. & Zelenetz, A. D., Nov 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 11, p. 1414-1427 14 p.

Research output: Contribution to journalReview article

High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)

Wagner-Johnston, N., Lensing, S., Noy, A., Ratner, L., Henry, D., Lee, J. Y., Silver, S., Faham, M. & Ambinder, R. F., May 15 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle